Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa.
Houreratou BarryGaudensia MutuaHannah KibuukaZacchaeus AnywaineSodiomon Bienvenu SirimaNicolas MedaOmu AnzalaSerge EholieChristine BétardLaura RichertChristine LacabaratzM Juliana McElrathStephen De RosaKristen W CohenGeorgi ShukarevCynthia RobinsonAuguste GaddahDirk HeerweghViki BockstalKerstin LuhnMaarten LeyssenMacaya DouoguihRodolphe Thiebautnull nullPublished in: PLoS medicine (2021)
ClinicalTrials.gov NCT02564523.